Alopecia in Association with Malignancy: A Review

August 2018 in “ American Journal of Clinical Dermatology ”

Poonkiat Suchonwanit, Amy J. McMichael

alopecia neoplastica treatment-related alopecia paraneoplastic alopecia biopsy chemotherapy-induced alopecia CIA radiation-induced alopecia RIA scalp cooling permanent alopecia telogen effluvium alopecia areata alopecia mucinosa chemotherapy-induced hair loss radiation-induced hair loss

TLDR Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The document reviewed the relationship between alopecia and cancer, categorizing hair loss in cancer patients into alopecia neoplastica, treatment-related alopecia, and paraneoplastic alopecia. It highlighted that alopecia neoplastica requires biopsy for diagnosis, chemotherapy-induced alopecia (CIA) is common and usually reversible but can be permanent, and radiation-induced alopecia (RIA) can also be temporary or permanent based on radiation dose. Scalp cooling was discussed as an effective prevention for CIA, and the need for further research on permanent alopecia was emphasized. Additionally, paraneoplastic alopecia conditions like telogen effluvium, alopecia areata, and alopecia mucinosa were described, with their potential links to malignancies. The document stressed the importance of recognizing alopecia in cancer patients for diagnosis and improving quality of life, and disclosed one author's lack of conflicts of interest and the other's multiple affiliations with healthcare companies.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

50 / 50 results

research Hair Disorders in Patients with Cancer

53 citations , April 2018 in “Journal of The American Academy of Dermatology”

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

research Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer

67 citations , April 2018 in “JAMA Dermatology”

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

research Pathogenesis and Treatment Options for Chemotherapy-Induced Alopecia: A Systematic Review

34 citations , January 2018 in “International Journal of Dermatology”

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

research Skin Manifestations of Targeted Antineoplastic Therapy

8 citations , November 2017 in “Current problems in dermatology”

Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.

research Scalp Hypothermia as a Preventative Measure for Chemotherapy-Induced Alopecia: A Review of Controlled Clinical Trials

37 citations , October 2017 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

Scalp cooling effectively reduces hair loss from chemotherapy.

Permanent Alopecia in Patients with Breast Cancer After Taxane Chemotherapy and Adjuvant Hormonal Therapy: Clinicopathologic Findings in a Cohort of 10 Patients

research Permanent Alopecia in Patients with Breast Cancer After Taxane Chemotherapy and Adjuvant Hormonal Therapy: Clinicopathologic Findings in a Cohort of 10 Patients

31 citations , March 2017 in “Journal of The American Academy of Dermatology”

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

research Chemotherapy-Induced Alopecia Management: Clinical Experience and Practical Advice

48 citations , February 2017 in “Journal of Cosmetic Dermatology”

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

research PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia

38 citations , January 2017 in “PPAR Research”

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

research Immune-Related Alopecia (Areata and Universalis) in Cancer Patients Receiving Immune Checkpoint Inhibitors

87 citations , December 2016 in “British journal of dermatology/British journal of dermatology, Supplement”

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

research Desmoplastic Melanoma Presenting as Primary Alopecia Neoplastica: A Report of Two Cases

8 citations , June 2016 in “Journal of Cutaneous Pathology”

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

research Hair and Nail Adverse Events During Treatment with Targeted Therapies for Metastatic Melanoma

32 citations , May 2016 in “European journal of dermatology/EJD. European journal of dermatology”

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

research Proposing a Simpler Classification of Telogen Effluvium

21 citations , January 2016 in “Skin appendage disorders”

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

research Clinical and Histological Study of Permanent Alopecia After Bone Marrow Transplantation

23 citations , December 2015 in “Anais Brasileiros de Dermatologia”

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

research Alopecia in Patients Treated with Molecularly Targeted Anticancer Therapies

44 citations , September 2015 in “Annals of Oncology”

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

research Treatment of Permanent Chemotherapy-Induced Alopecia with Low Dose Oral Minoxidil

36 citations , May 2015 in “Australasian Journal of Dermatology”

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

research Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma

16 citations , March 2015 in “Clinical Cancer Research”

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

research Permanent Chemotherapy-Induced Nonscarring Alopecia and Premature Ovarian Failure

5 citations , March 2015 in “Clinical and Experimental Dermatology”

Chemotherapy caused a woman's permanent hair loss and early menopause.

research Cutaneous Adverse Effects of Targeted Therapies

192 citations , January 2015 in “Journal of the American Academy of Dermatology”

Targeted cancer therapies often cause serious skin problems that need careful management.

research Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management

68 citations , January 2014 in “Dermatology research and practice”

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

research Dermoscopic Findings in Radiation-Induced Alopecia After Angioembolization

13 citations , January 2014 in “Dermatology”

Radiation-induced alopecia after angioembolization usually heals on its own and can look like other hair loss types, but patient history helps prevent misdiagnosis.

research Alopecia With Endocrine Therapies in Patients With Cancer

48 citations , September 2013 in “Oncologist”

Endocrine therapies for cancer significantly increase the risk of hair loss.

research Pathobiology of Chemotherapy-Induced Hair Loss

218 citations , January 2013 in “The Lancet Oncology”

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

research Radiation- and Chemotherapy-Induced Permanent Alopecia: Case Series

14 citations , January 2013 in “Journal of Cutaneous Medicine and Surgery”

Some cancer treatments can cause permanent hair loss.

research Anagen Effluvium: A Review of Rapid Hair Loss During Growth Phase and Loose Anagen Hair Syndrome

61 citations , January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

research Exclamation Marks and Other Trichoscopic Signs of Chemotherapy-Induced Alopecia

33 citations , September 2012 in “Australasian Journal of Dermatology”

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Permanent Scalp Alopecia Related to Breast Cancer Chemotherapy by Sequential Fluorouracil/Epirubicin/Cyclophosphamide (FEC) and Docetaxel: A Prospective Study of 20 Patients

research Permanent Scalp Alopecia Related to Breast Cancer Chemotherapy by Sequential Fluorouracil/Epirubicin/Cyclophosphamide (FEC) and Docetaxel: A Prospective Study of 20 Patients

68 citations , May 2012 in “Annals of Oncology”

Some breast cancer chemotherapy can cause permanent hair loss.

research Late-Onset Alopecia Areata: A Retrospective Study of 73 Patients from Taiwan

21 citations , February 2012 in “Journal of the European Academy of Dermatology and Venereology”

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

research Chemotherapy-Induced Alopecia

103 citations , December 2011 in “Journal of the American Academy of Dermatology”

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

research Multiple Paraneoplastic Syndromes: Myasthenia Gravis, Vitiligo, Alopecia Areata, and Oral Lichen Planus Associated with Thymoma

31 citations , June 2011 in “Journal of the neurological sciences”

Removing the thymoma improved the man's autoimmune conditions.

research Permanent Alopecia After Systemic Chemotherapy: A Clinicopathological Study of 10 Cases

57 citations , March 2011 in “The American Journal of Dermatopathology”

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

research The Spectrum of Hair Loss in Patients with Mycosis Fungoides and Sézary Syndrome

39 citations , October 2010 in “Journal of The American Academy of Dermatology”

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

research Biology and Genetics of Hair

89 citations , September 2010 in “Annual Review of Genomics and Human Genetics”

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

research Permanent Chemotherapy-Induced Alopecia: Case Report and Review of the Literature

67 citations , May 2010 in “Journal of The American Academy of Dermatology”

Some chemotherapy can cause permanent hair loss.

research Alopecia Areata Update

391 citations , January 2010 in “Journal of The American Academy of Dermatology”

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

research Radiation-Induced Alopecia

17 citations , January 2010 in “International journal of trichology”

A man experienced hair loss from radiotherapy, which can be temporary or permanent depending on radiation dose, with potential treatments available.

research Irreversible And Severe Alopecia Following Docetaxel Or Paclitaxel Cytotoxic Therapy For Breast Cancer

61 citations , April 2009 in “British journal of dermatology/British journal of dermatology, Supplement”

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

research Chemotherapy-Induced Alopecia: Emotional Distress and Mitigation Strategies

155 citations , March 2009 in “Seminars in Cutaneous Medicine and Surgery”

Scalp cooling might reduce hair loss from chemotherapy, but evidence is weak and other treatments are being tested.

research Malignancy and Cancer Treatment-Related Hair and Nail Changes

43 citations , November 2007 in “Dermatologic Clinics”

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

research Six Cases of Permanent Alopecia After Various Conditioning Regimens Commonly Used in Hematopoietic Stem Cell Transplantation

40 citations , September 2007 in “Bone marrow transplantation”

Certain chemotherapy drugs can cause permanent hair loss in stem cell transplant patients.

research Drug Reactions Affecting Hair: Diagnosis

85 citations , April 2007 in “Dermatologic Clinics”

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

research Cervical Cancer Metastasis to the Scalp Presenting as Alopecia Neoplastica

24 citations , February 2007 in “International Journal of Dermatology”

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

research Review of Scalp Alopecia Due to a Clinically Unapparent or Minimally Apparent Neoplasm (SACUMAN)

32 citations , January 2006 in “Acta dermato-venereologica”

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

research The Preventive Effect of Vitamin D3 on Radiation-Induced Hair Toxicity in a Rat Model

14 citations , November 2005 in “Life sciences”

Vitamin D3 may protect rat hair follicles from radiation damage.

research Alopecia Neoplastica Caused by Desmoplastic Melanoma

24 citations , November 2003 in “Australasian Journal of Dermatology”

A rare skin cancer caused hair loss and spread, needing multiple treatments.

research Telogen Effluvium: Causes, Diagnosis, and Treatment

144 citations , July 2002 in “Clinical and Experimental Dermatology”

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

research Hair and Systemic Disease

58 citations , October 2001 in “Dermatologic Clinics”

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

research Permanent Alopecia Following Chemotherapy and Bone Marrow Transplantation

63 citations , May 2000 in “Australasian Journal of Dermatology”

Chemotherapy and bone marrow transplant can cause permanent hair loss.

research A Randomized Trial of Minoxidil in Chemotherapy-Induced Alopecia

127 citations , July 1996 in “Journal of The American Academy of Dermatology”

Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.

research Telogen Effluvium: A Comprehensive Review

214 citations , March 1993 in “Archives of Dermatology”

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

research Pregnancy, Hair Loss, and the Pill

23 citations , October 1971 in “BMJ”

Stopping the pill and giving birth both caused hair loss.

Similar Research

5 / 1000+ results

research Cancer-Related Alopecia: From Etiologies to Global Management

4 citations , November 2021 in “Cancers”

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

research Malignancy and Cancer Treatment-Related Hair and Nail Changes

43 citations , November 2007 in “Dermatologic Clinics”

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

research Alopecia as a Systemic Disease

7 citations , July 2019 in “Clinics in Dermatology”

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

research General Dermatology: Comprehensive Overview of Dermatological Conditions

January 2017 in “Springer eBooks”

The document explains various skin conditions and their treatments.

research Mucocutaneous Reactions to Chemotherapy

275 citations , March 1999 in “Journal of The American Academy of Dermatology”

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.